Home > M&A deals 2016 > LeMaitre Vascular, Inc. acquires ProCol Vascular Bioprosthesis
Divestiture · Medical Products · March 2016

LeMaitre Vascular, Inc. acquires ProCol Vascular Bioprosthesis

On March 18, 2016, LeMaitre Vascular, Inc. acquired ProCol Vascular Bioprosthesis, a medical products company in United States, from CryoLife, Inc.

Deal at a glance

AnnouncedMarch 18, 2016 TypeDivestiture TargetProCol Vascular Bioprosthesis Buyer LeMaitre Vascular, Inc. Seller CryoLife, Inc. SectorMedical Products LocationUnited States ValueNot disclosed

Target company

ProCol Vascular Bioprosthesis
United States
Medical Productssector
-founded
Activestatus
View the company profile →

Buyer

LeMaitre Vascular, Inc.
Company · 8 deals on record
  • 1st transaction in medical products
  • 2nd transaction in United States
8deals, all time
2in this sector
2020latest

Seller

CryoLife, Inc.
Company · 11 deals on record
11investments
6in this sector
4exits

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

Seraplex, Inc.Same sector and country · Oct 2026
Aloe Care Health, Inc.Same sector and country · Apr 2026
Hologic, Inc.Same sector and country · Apr 2026

Questions about this deal

Who acquired ProCol Vascular Bioprosthesis?LeMaitre Vascular, Inc. acquired ProCol Vascular Bioprosthesis on March 18, 2016.

Who sold ProCol Vascular Bioprosthesis?CryoLife, Inc. was the seller.

What type of deal was it?It was a divestiture in the medical products sector in 2016.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).